id: il17_signaling_to_chronic_pancreatitis
name: IL-17 Signaling Pathway â†’ Chronic Pancreatitis
from_node:
  node_id: il17_signaling
  node_name: IL-17 Signaling Pathway
to_node:
  node_id: chronic_pancreatitis
  node_name: Chronic Pancreatitis
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: IL-17A and related cytokines (CCL20) are produced by Th17 cells in response
  to chronic inflammatory stimuli'
- 'Step 2: IL-17 signaling promotes recruitment of neutrophils and macrophages to
  pancreatic tissue'
- 'Step 3: Sustained IL-17-mediated inflammation drives fibrosis and tissue remodeling
  in the pancreas'
- 'Step 4: Chronic IL-17 pathway activation distinguishes chronic pancreatitis from
  acute and recurrent disease states'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: Bomi Lee et al. 2023. "Distinct serum immune profiles define the
    spectrum of acute and chronic pancreatitis from the multi-center PROCEED study.."
    *Gastroenterology*. https://doi.org/10.1053/j.gastro.2023.03.236
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.178450'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: disease_progression_stage
  direction: strengthens
  strength: strong
  description: IL-17 signaling specifically distinguishes chronic pancreatitis from
    earlier disease stages (acute pancreatitis, recurrent acute pancreatitis, and
    chronic abdominal pain)
